Literature DB >> 12066972

Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.

Shana Digwood-Lettieri1, Kathleen J Reilly, Linwood R Haith, Mary L Patton, Robert J Guilday, Michael J Cawley, Bruce H Ackerman.   

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN) are mild-to-life-threatening adverse reactions that have been described after exposure to fluoroquinolones. No published reports, however, exist of exfoliative disease after treatment with levofloxacin. A 78-year-old woman with many medical problems, including chronic obstructive pulmonary disease, was treated with parenteral levofloxacin for community-acquired pneumonia. She was discharged with oral levofloxacin to complete an additional 3 days of treatment as an outpatient. Two days after completing this regimen, the patient developed a rash with blistering. The rash progressed to TEN in 7 days, and she was transferred to a burn treatment center. She was treated with fluid resuscitation, wound dressing, and antibiotics. Her condition improved, and she was discharged after 22 days. To our knowledge, this case is the first published report of levofloxacin-induced TEN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12066972     DOI: 10.1592/phco.22.9.789.34074

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

Review 1.  Drug-hypersensitivity syndrome: diagnosis and treatment.

Authors:  Rose L Hamm
Journal:  J Am Coll Clin Wound Spec       Date:  2012-06-23

2.  Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment.

Authors:  Tae-Ok Kim; Hong-Joon Shin; Yu-Il Kim; Sung-Chul Lim; Young-Il Koh; Yong-Soo Kwon
Journal:  Korean J Intern Med       Date:  2019-03-19       Impact factor: 2.884

Review 3.  An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS.

Authors:  Koraisha Hoosen; Anisa Mosam; Ncoza Cordelia Dlova; Wayne Grayson
Journal:  Dermatopathology (Basel)       Date:  2019-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.